These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11894008)

  • 21. Therapeutic angiogenesis inhibitors in the treatment of cancer.
    Hidalgo M; Pierson AS; Holden SN; Bergen M; Eckhardt SG
    Adv Intern Med; 2001; 47():159-90. PubMed ID: 11795074
    [No Abstract]   [Full Text] [Related]  

  • 22. [French clinical research in thoracic oncology].
    Morin F
    Rev Pneumol Clin; 2004 Nov; 60(5 Pt 3):4S44-4S45. PubMed ID: 15687994
    [No Abstract]   [Full Text] [Related]  

  • 23. Mechanisms of evasion to antiangiogenic therapy in glioblastoma.
    Rose SD; Aghi MK
    Clin Neurosurg; 2010; 57():123-8. PubMed ID: 21280504
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical implications of EGFR expression in the development and progression of solid tumors: focus on non-small cell lung cancer.
    Ettinger DS
    Oncologist; 2006 Apr; 11(4):358-73. PubMed ID: 16614231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances in the diagnosis and treatment of lung cancer.
    Liam CK; Lim KH; Wong MM
    Med J Malaysia; 2001 Dec; 56(4):514-31; quiz 532. PubMed ID: 12014776
    [No Abstract]   [Full Text] [Related]  

  • 26. Apoptosis in oncology.
    Fan XQ; Guo YJ
    Cell Res; 2001 Mar; 11(1):1-7. PubMed ID: 11305320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitors of angiogenesis: new hopes for oncologists, new challenges for anesthesiologists.
    Libert N; Tourtier JP; Védrine L; Chargari C
    Anesthesiology; 2010 Sep; 113(3):704-12. PubMed ID: 20693871
    [No Abstract]   [Full Text] [Related]  

  • 28. Targeting epidermal growth factor receptor signaling: early results and future trends in oncology.
    Lage A; Crombet T; González G
    Ann Med; 2003; 35(5):327-36. PubMed ID: 12952019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comments on: management of proliferative diabetic retinopathy.
    Khorrami AM
    Compr Ophthalmol Update; 2007; 8(5):257-8. PubMed ID: 18201512
    [No Abstract]   [Full Text] [Related]  

  • 30. Bevacizumab in lung cancer: hurdles in clinical development.
    Pirker R
    Lancet Oncol; 2010 Aug; 11(8):703-4. PubMed ID: 20650687
    [No Abstract]   [Full Text] [Related]  

  • 31. Bevacizumab in advanced lung cancer: in search of the right drug for the right patient.
    Burns TF; Juergens RA
    Oncology (Williston Park); 2010 Nov; 24(13):1223-4, 1226. PubMed ID: 21192562
    [No Abstract]   [Full Text] [Related]  

  • 32. Targeting angiogenesis driven by vascular endothelial growth factors using antibody-based therapies.
    Grothey A; Ellis LM
    Cancer J; 2008; 14(3):170-7. PubMed ID: 18536556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Oncology 1999: advances in immunotherapy].
    Cerny T
    Schweiz Med Wochenschr; 2000 Jan; 130(1-2):21-4. PubMed ID: 10670041
    [No Abstract]   [Full Text] [Related]  

  • 34. Progress in the treatment of metastatic non-small-cell lung cancer: slow but steady!
    Ramnath N; Govindan R
    Clin Lung Cancer; 2009 Jul; 10(4):260-1. PubMed ID: 19632945
    [No Abstract]   [Full Text] [Related]  

  • 35. Oncology today: new horizons. Lung cancer.
    Dest VM
    RN; 2000 May; 63(5):32-6, 38; quiz 41. PubMed ID: 10865695
    [No Abstract]   [Full Text] [Related]  

  • 36. Targeted therapy.
    Chu E
    Clin Colorectal Cancer; 2007 Jan; 6(5):336. PubMed ID: 17311696
    [No Abstract]   [Full Text] [Related]  

  • 37. [Structuring the French thoracic oncology over the last 20 years].
    Milleron B
    Rev Mal Respir; 2017 Nov; 34(9):973-975. PubMed ID: 29033204
    [No Abstract]   [Full Text] [Related]  

  • 38. Novel molecular and immunotherapeutic strategies for lung cancer.
    Pass HI; Kalemkerian G; Bright RK
    Chest Surg Clin N Am; 2001 Feb; 11(1):189-212, ix. PubMed ID: 11253598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor targeting with monoclonal antibodies. Advances in the Applications of Monoclonal Antibodies in Clinical Oncology, symposium. Porto Carras, Halkidiki, Greece, May 4-6, 1992.
    Cell Biophys; 1993; 22(1-3):1-246. PubMed ID: 7889534
    [No Abstract]   [Full Text] [Related]  

  • 40. New antileukemic agents.
    Mantadakis E; Kalmanti M
    Pediatr Hematol Oncol; 2003; 20(3):173-85. PubMed ID: 12637214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.